Meloxicam

Product NDC: 61442-127
Requested package NDC: 61442-127-01
11-digit product format: 614420127
Labeler code: 61442
Product ID: 61442-127_34303a6a-f321-bc83-e063-6294a90a4e79
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Meloxicam
Dosage form: TABLET
Route: ORAL
Labeler: Carlsbad Technology, Inc.
Application: ANDA077918
Marketing category: ANDA
Marketing start: 2010-06-30
Substance: MELOXICAM
Active strength: 15 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	61442-127	61442-127-01	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077918-001	MELOXICAM	MELOXICAM	7.5MG	TABLET / ORAL	AB		2006-12-07
A077918-002	MELOXICAM	MELOXICAM	15MG	TABLET / ORAL	AB		2006-12-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A077918-001	AB
A077918-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077918-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-12-07	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077918-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-12-07	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077918-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077918-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077918-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077918-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077918-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077918-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077918-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077918-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077918-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077918-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077918-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077918-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077918-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077918-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077918-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077918-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077918-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077918-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077918-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077918-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077918-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077918-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077918-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077918-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077918-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077918-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077918-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077918-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077918-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077918-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077918-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077918-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077918-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077918-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077918-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077918-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077918-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077918-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077918-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077918-002	AB	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Meloxicam
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
MELOXICAM	15 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
VG2QF83CGL	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
152695	Internal RxNorm lookup
311486	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
20871c7f-1e36-49ef-8e2b-70112430ca1e	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bdef11ce-16e2-4690-96a3-597bcf5cc738	Product name	1	20260130
f2791553-0b76-42f4-8d49-af3eda072bfb	Product name	1	20251117
e3a99641-4540-4894-9108-00cab3c57b7e	Product name	1	20211207
3e9b4ed6-844c-4725-9d19-cceb5c823572	Product name	2	20210903
b21a682e-c765-4e26-9bb2-dbb8c7b38ef7	Product name	1	20200623
a428d1db-64d7-4fc3-8d13-832b1e84b683	Product name	1	20190201
96649a58-aac8-401c-be00-450b4335f7e7	Product name	1	20161116
f0761cb7-8207-3a19-2ca3-ecbb559b04e1	Product name	2	20161116
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
61442-127-01	2023-02-20	These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP for oral use Initial U.S. Approval: 2000
61442-127-10	2023-02-20	These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP for oral use Initial U.S. Approval: 2000
61442-127-30	2023-02-20	These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP for oral use Initial U.S. Approval: 2000
61442-127-01	2023-01-30	These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP for oral use Initial U.S. Approval: 2000
61442-127-10	2023-01-30	These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP for oral use Initial U.S. Approval: 2000
61442-127-30	2023-01-30	These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP for oral use Initial U.S. Approval: 2000

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
61442-127-01	Meloxicam	100 in 1 BOTTLE, PLASTIC	TABLET	100	17
61442-127-10	Meloxicam	1000 in 1 BOTTLE, PLASTIC	TABLET	1000	17
61442-127-30	Meloxicam	30 in 1 BOTTLE, PLASTIC	TABLET	30	17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61442-127-01	EA - Each	61442-127	524b389e-3feb-4fa0-87f1-9083a826d06d	1	2012-07-24
61442-127-10	EA - Each	61442-127	1fa406b3-5839-4cb8-bfcb-18b343de4a9f	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Meloxicam	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
Meloxicam	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
Colloidal Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
Magnesium Stearate	INACTIVE INGREDIENT	70097M6I30	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
Povidone K30	INACTIVE INGREDIENT	U725QWY32X	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
Sodium Citrate	INACTIVE INGREDIENT	1Q73Q2JULR	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	MELOXICAM TABLET [PD-RX PHARMACEUTICALS, INC.]	11
MELOXICAM	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
Meloxicam	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM TABLET [READYMEDS]	10
Meloxicam	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM TABLET [READYMEDS]	10
MELOXICAM	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM TABLET [READYMEDS]	10
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
Colloidal Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM TABLET [READYMEDS]	10
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	MELOXICAM TABLET [READYMEDS]	10
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
Magnesium Stearate	INACTIVE INGREDIENT	70097M6I30	MELOXICAM TABLET [READYMEDS]	10
Povidone K30	INACTIVE INGREDIENT	U725QWY32X	MELOXICAM TABLET [READYMEDS]	10
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
Sodium Citrate	INACTIVE INGREDIENT	1Q73Q2JULR	MELOXICAM TABLET [READYMEDS]	10
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	MELOXICAM TABLET [READYMEDS]	10
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	10
MELOXICAM	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
MELOXICAM	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	MELOXICAM TABLET [BLENHEIM PHARMACAL, INC.]	5
Meloxicam	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Meloxicam	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Magnesium Stearate	INACTIVE INGREDIENT	70097M6I30	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Povidone K30	INACTIVE INGREDIENT	U725QWY32X	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Sodium Citrate	INACTIVE INGREDIENT	1Q73Q2JULR	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Sodium Starch Glycolate Type A Potato	INACTIVE INGREDIENT	5856J3G2A2	MELOXICAM (MELOXICAM) TABLET [AVPAK]	4
Meloxicam	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
Meloxicam	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
Magnesium Stearate	INACTIVE INGREDIENT	70097M6I30	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
Povidone K30	INACTIVE INGREDIENT	U725QWY32X	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
Sodium Citrate	INACTIVE INGREDIENT	1Q73Q2JULR	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
Sodium Starch Glycolate Type A Potato	INACTIVE INGREDIENT	5856J3G2A2	MELOXICAM TABLET [DISPENSING SOLUTIONS, INC.]	2
MELOXICAM	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1
MELOXICAM	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	MELOXICAM TABLET [MEDSOURCE PHARMACEUTICALS]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61442-127	MELOXICAM TABLET [CARLSBAD TECHNOLOGY, INC.]	16	Current NDC, Legacy NDC, 3 package rows	20250112_20871c7f-1e36-49ef-8e2b-70112430ca1e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 13 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Meloxicam	MELOXICAM	PD-Rx Pharmaceuticals, Inc.	1ab45be4-b2b9-4374-95ab-620e0f90fb70	2026-04-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	PD-Rx Pharmaceuticals, Inc.	eae60d2c-411c-460a-b673-05b5784ed943	2026-04-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Golden State Medical Supply, Inc.	d27feaf7-731e-1a8f-e053-2a95a90afa71	2026-02-18	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	AvPAK	ee8df8fa-d08a-8c8b-f048-813e5022a101	2025-09-16	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Carlsbad Technology, Inc.	20871c7f-1e36-49ef-8e2b-70112430ca1e	2025-05-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918 ndc (package): 61442-127-01 ndc (product): 61442-127 ndc11 (package): 61442012701
Meloxicam	MELOXICAM	Bryant Ranch Prepack	d3182622-4b9b-4850-bf9f-108c5610eb40	2025-04-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Bryant Ranch Prepack	ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf	2025-03-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Bryant Ranch Prepack	75af3e09-f510-45a4-9f21-50bff7aa5510	2025-03-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Bryant Ranch Prepack	218e71c6-265a-45f4-b660-5c1da5a36bd2	2025-03-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Aphena Pharma Solutions - Tennessee, LLC	e1603665-bbce-48b3-9424-3646570ae9b8	2022-08-17	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Proficient Rx LP	b5d72a30-3d32-45ad-be81-3fe601d8912b	2022-04-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Aphena Pharma Solutions - Tennessee, LLC	8f43b954-d1cb-4210-b479-5292c446cc74	2021-05-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918
Meloxicam	MELOXICAM	Aphena Pharma Solutions - Tennessee, LLC	2a29daa9-74e5-4ed6-b5f1-ce04dc411b26	2020-07-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077918 application number: ANDA077918

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
VG2QF83CGL	MELOXICAM	71125-38-7	MELOXICAM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
152695	meloxicam 15 MG Oral Tablet	PSN	218e71c6-265a-45f4-b660-5c1da5a36bd2	103
152695	meloxicam 15 MG Oral Tablet	SCD	218e71c6-265a-45f4-b660-5c1da5a36bd2	103
152695	meloxicam 15 MG Oral Tablet	PSN	ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf	102
152695	meloxicam 15 MG Oral Tablet	SCD	ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf	102
152695	meloxicam 15 MG Oral Tablet	PSN	d3182622-4b9b-4850-bf9f-108c5610eb40	101
152695	meloxicam 15 MG Oral Tablet	SCD	d3182622-4b9b-4850-bf9f-108c5610eb40	101
152695	meloxicam 15 MG Oral Tablet	PSN	eae60d2c-411c-460a-b673-05b5784ed943	32
152695	meloxicam 15 MG Oral Tablet	SCD	eae60d2c-411c-460a-b673-05b5784ed943	32
152695	meloxicam 15 MG Oral Tablet	PSN	20871c7f-1e36-49ef-8e2b-70112430ca1e	17
311486	meloxicam 7.5 MG Oral Tablet	PSN	20871c7f-1e36-49ef-8e2b-70112430ca1e	17
152695	meloxicam 15 MG Oral Tablet	SCD	20871c7f-1e36-49ef-8e2b-70112430ca1e	17
311486	meloxicam 7.5 MG Oral Tablet	SCD	20871c7f-1e36-49ef-8e2b-70112430ca1e	17
152695	meloxicam 15 MG Oral Tablet	PSN	ee8df8fa-d08a-8c8b-f048-813e5022a101	10
152695	meloxicam 15 MG Oral Tablet	PSN	8b2aa351-4ac3-4b5f-a20c-060805812cd0	10
311486	meloxicam 7.5 MG Oral Tablet	PSN	ee8df8fa-d08a-8c8b-f048-813e5022a101	10
311486	meloxicam 7.5 MG Oral Tablet	PSN	8b2aa351-4ac3-4b5f-a20c-060805812cd0	10
152695	meloxicam 15 MG Oral Tablet	SCD	ee8df8fa-d08a-8c8b-f048-813e5022a101	10
152695	meloxicam 15 MG Oral Tablet	SCD	8b2aa351-4ac3-4b5f-a20c-060805812cd0	10
311486	meloxicam 7.5 MG Oral Tablet	SCD	ee8df8fa-d08a-8c8b-f048-813e5022a101	10
311486	meloxicam 7.5 MG Oral Tablet	SCD	8b2aa351-4ac3-4b5f-a20c-060805812cd0	10
152695	meloxicam 15 MG Oral Tablet	PSN	55a30270-6082-452b-a081-657d51378e84	5
152695	meloxicam 15 MG Oral Tablet	PSN	d27feaf7-731e-1a8f-e053-2a95a90afa71	5
311486	meloxicam 7.5 MG Oral Tablet	PSN	d27feaf7-731e-1a8f-e053-2a95a90afa71	5
152695	meloxicam 15 MG Oral Tablet	SCD	55a30270-6082-452b-a081-657d51378e84	5
152695	meloxicam 15 MG Oral Tablet	SCD	d27feaf7-731e-1a8f-e053-2a95a90afa71	5
311486	meloxicam 7.5 MG Oral Tablet	SCD	d27feaf7-731e-1a8f-e053-2a95a90afa71	5
152695	meloxicam 15 MG Oral Tablet	PSN	2a29daa9-74e5-4ed6-b5f1-ce04dc411b26	2
152695	meloxicam 15 MG Oral Tablet	PSN	8685a269-d533-4970-889e-d70e8b958ccd	2
152695	meloxicam 15 MG Oral Tablet	PSN	b5d72a30-3d32-45ad-be81-3fe601d8912b	2
311486	meloxicam 7.5 MG Oral Tablet	PSN	b5d72a30-3d32-45ad-be81-3fe601d8912b	2
152695	meloxicam 15 MG Oral Tablet	SCD	8685a269-d533-4970-889e-d70e8b958ccd	2
152695	meloxicam 15 MG Oral Tablet	SCD	2a29daa9-74e5-4ed6-b5f1-ce04dc411b26	2
152695	meloxicam 15 MG Oral Tablet	SCD	b5d72a30-3d32-45ad-be81-3fe601d8912b	2
311486	meloxicam 7.5 MG Oral Tablet	SCD	b5d72a30-3d32-45ad-be81-3fe601d8912b	2
152695	meloxicam 15 MG Oral Tablet	PSN	2adb9f9b-c49c-4137-9e2e-8be9065639e6	1
152695	meloxicam 15 MG Oral Tablet	SCD	2adb9f9b-c49c-4137-9e2e-8be9065639e6	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
61442-127-01	61442012701	100 TABLET in 1 BOTTLE, PLASTIC (61442-127-01)	100 tablet	2010-06-30	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Meloxicam	PD-Rx Pharmaceuticals, Inc.	2026-04-29	HUMAN PRESCRIPTION DRUG LABEL	32
Meloxicam	Golden State Medical Supply, Inc.	2026-02-18	HUMAN PRESCRIPTION DRUG LABEL	5
Meloxicam	AvPAK	2025-09-16	HUMAN PRESCRIPTION DRUG LABEL	10
Meloxicam	Carlsbad Technology, Inc. \| Yung Shin Pharmaceutical Industrual Co., Ltd. \| Yung Shin Pharmaceutical Industrial Co., Ltd.	2025-05-02	HUMAN PRESCRIPTION DRUG LABEL	17
Meloxicam	Bryant Ranch Prepack	2025-04-01	HUMAN PRESCRIPTION DRUG LABEL	101
Meloxicam	Bryant Ranch Prepack	2025-03-31	HUMAN PRESCRIPTION DRUG LABEL	102
Meloxicam	Bryant Ranch Prepack	2025-03-19	HUMAN PRESCRIPTION DRUG LABEL	103
Meloxicam	Proficient Rx LP	2022-04-01	HUMAN PRESCRIPTION DRUG LABEL	2
Meloxicam	Aphena Pharma Solutions - Tennessee, LLC	2020-07-20	HUMAN PRESCRIPTION DRUG LABEL	2
Meloxicam	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	2020-06-01	HUMAN PRESCRIPTION DRUG LABEL	6
Meloxicam	Blenheim Pharmacal, Inc.	2015-11-24	HUMAN PRESCRIPTION DRUG LABEL	5
Meloxicam	ReadyMeds	2014-07-01	HUMAN PRESCRIPTION DRUG LABEL	10
Meloxicam	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2013-07-05	HUMAN PRESCRIPTION DRUG LABEL	2
Meloxicam	Medsource Pharmaceuticals	2012-07-24	HUMAN PRESCRIPTION DRUG LABEL	1